{"acquisitions":[],"changes":[],"country":"US","description":"SBIR Phase II award from Department of Health and Human Services (National Institutes of Health): Phase II- Repurposing CRH antagonists for the treatment of endometriosis","domain":"sur180therapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":26.204114,"lng":-98.23006,"location":"Mcallen, Texas, USA","multiples":[],"name":"SUR180 THERAPEUTICS, INC.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":1239987,"connectionsAmong":[],"currency":"USD","date":"2025-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"sur180therapeutics-com-2025-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"sur180therapeutics-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"sur180therapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://sur180therapeutics.com"},{"fact":"description","publisher":"sur180therapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://sur180therapeutics.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Google Cloud CDN","Sentry","Vercel Speed Insights","WebsiteBuilder","Wix","Google Cloud","React","lodash ."],"totalRaisedUsd":1239987,"traction":[],"updatedAt":"2026-05-08","valuations":[]}